MedPath

A clinical trial to study the effects of two drugsDydrogesterone and micronized progesterone in pregnant women with threatened abortion

Not Applicable
Conditions
Health Condition 1: O200- Threatened abortion
Registration Number
CTRI/2020/10/028244
Lead Sponsor
department of Obstetrics and gynaecology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Gestational age less than 12weeks of gestation in women with threatened abortion.

Singleton intrauterine live pregnancy.

Women aged from 20 to 35 years.

Exclusion Criteria

History of recurrent miscarriage (defined as at least three consecutive spontaneous miscarriages).

History of cervical surgery.

Heavy vaginal bleeding requiring surgical intervention.

Any uterine anomalies.

Any associated medical and surgical illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Miscarriage before 20 weeks of gestationTimepoint: Miscarriage rate, time points :20 weeks of gestation
Secondary Outcome Measures
NameTimeMethod
ive birth rate <br/ ><br>Period of gestational age at delivery <br/ ><br>Birth weight at delivery <br/ ><br>Antepartum haemorrhage <br/ ><br>Pre-eclampsia <br/ ><br>Timepoint: 20weeks to till delivery
© Copyright 2025. All Rights Reserved by MedPath